Among 6,244 participants in the MESA study population free of CVD and self-reported cancer at baseline at Exam 1, 6,035 and 6,043 participants were included in the analyses for the association of hs-cTnT and NT-proBNP, respectively, with incident cancer. This evidence concerns the gene TNNT2 and cancer.